Bliss GVS Pharma Limited appointed Mr. Deepak Sawant as Chief Financial Officer with effect from December 30, 2022. Mr. Deepak Sawant aged 43 years was appointed as Company's DGM ­ Accounts and Finance on March 16, 2020. Mr. Sawant is a qualified Chartered Accountant and holds Bachelor of Commerce degree from Mumbai University.

He has more than 20 years of post-qualification work experience having extensive expertise in Finance and Accounts, Taxation, Financial and Strategic Planning, Fund management. Prior to joining the Company, he was associated with companies like Enaltec Labs Pharma Pvt. Ltd., FDC Ltd. and Zoetis India Ltd. He has rich experience in leadership role managing finance and accounts function majorly in pharmaceutical sector.

He has extensive expertise in Strategy and financial planning, Corporate Finance, Treasury, Budgeting, Taxation. He has track record of leading teams, strengthening operational and financial controls, driving operational efficiency. Mr. Sawant shall be responsible for Strategy, Accounting, Treasury, Financial Planning & Analysis and Taxation.

Mr. Deepak Sawant is not related to any of the Directors or the Key Managerial Personnel or any of their relatives.